Altogether, these observations reveal differential relationships between different IFNs and clinical variables in COVID-19, with some IFNs being associated with the hyperinflammatory stage of the disease (e.g., IFNG), whereas others associate with markers of late severe disease, such as increased N/L ratio (e.g., IFNB1). This evidence concerns the gene IFNB1 and COVID-19.